An Exelixis Product for the Clinical Management of Neuroendocrine Tumors
When: Saturday, June 21, 2025, at 7:15 AM – 8:15 AM PT
Speaker Details: Brittney Carden, PharmD | USA Health Mitchell Cancer Institute | Specialty Pharmacy Manager | bcarden@health.southalabama.
Therapeutic Area of Focus: Neuroendocrine Tumors (NET)
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target a range of tumor types and indications to advance our investigational programs and extend the impact of our flagship commercial product. Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future.
____________________________________________
Register Here